Phase I trial of combined recombinant interleukin-2 with levamisole in patients with advanced malignant disease

T. G. Call, E. T. Creagan, S. Frytak, J. C. Buckner, C. Van Haelst-Pisani, H. A. Homburger, J. A. Katzmann

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I trial of combined recombinant interleukin-2 with levamisole in patients with advanced malignant disease'. Together they form a unique fingerprint.

Medicine & Life Sciences